← Eichor
Study identifier: NCT06277362 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Peripheral Extreme Revascularization in "No-option" Patiens With Chronic Limb Threatening Ischemia

Condition: Peripheral Arterial Disease · Critical Limb-Threatening Ischemia · Diabetic Foot  ·  Sponsor: EndoCore Lab s.r.l.

PhaseN/A
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The objective of the study is to evaluate early safety and effectiveness of the percutaneous deep foot venous arterialization performed in clinical practice, in an unselected population of patients with "no-option" CLTI.

This description comes directly from the study's public registry record.

Talk to the study team

Gabriele Morselli, PharmD  ·  +39 3499105666  ·  g.morselli@endocorelab.org

Bruno Migliara, MD  ·  bruno.migliara@gmail.com

Always discuss trial participation with your own doctor first.

Locations (9)

Irccs InrcaAncona, Ancona, ItalyRecruiting
Ospedale San MartinoBelluno, Italy, ItalyRecruiting
Ospedale BufaliniCesena, Italy, ItalyRecruiting
Ospedale di Conegliano - USLL2Conegliano, Italy, ItalyWithdrawn
Ospedale CardarelliNaples, Italy, ItalyRecruiting
Arcispedale Santa Maria NuovaReggio Emilia, Italy, ItalyWithdrawn
Ospedale Santa ChiaraTrento, Italy, ItalyRecruiting
Azienda Ospedaliera S. Maria della MisericordiaPerugia, Perugia, ItalyNot Yet Recruiting
Ospedale PederzoliPeschiera del Garda, Veneto, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06277362